Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population
Abstract Aims This analysis qualitatively describes the impact of hyperkalaemia (HK) and renin‐angiotensin‐aldosterone system inhibitor (RAASi) use on clinical outcomes in patients with heart failure (HF). Methods and results Patients were included if they were ≥18 years old; had a serum potassium r...
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Wiley
2021-02-01
|
| Edice: | ESC Heart Failure |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/ehf2.13164 |